Source: Annual Congress 2007 - Different aspects of COPD exacerbations
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
X. Pomares, C. Monton, M. Gallego, D. Mariscal, E. Castaner, J. Valles, A. Marin (Sabadell, Spain). C-reactive protein usefulness in diagnosis and follow-up of COPD infectious exacerbations. Eur Respir J 2007; 30: Suppl. 51, 1380

Member's Comments

No comment yet.

Related content which might interest you: C-reactive protein level and microbial aetiology in patients hospitalised with acute exacerbation of COPD Source: Eur Respir J 2015; 45: 76-86 Year: 2015 The importance of C-reactive protein in patients with acute exacerbation of severe COPD Source: International Congress 2019 – Airway disease-associated exacerbations Year: 2019 Utility of procalcitonin, neopterin, C-reactive protein and MR-proANP measurement in the management of exacerbations in chronic obstructive pulmonary disease Source: Annual Congress 2008 - Biomarkers and antibiotic treatment of exacerbations of COPD Year: 2008 C-reactive protein levels and clinically important predictive outcomes in stable COPD patients Source: Eur Respir J 2006; 27: 902-907 Year: 2006 Our experience of procalcitonin assay in identifying bacterial COPD exacerbations Source: Annual Congress 2011 - COPD exacerbation Year: 2011 Sputum purulence-guided antibiotic use in hospitalised patients with exacerbations of COPD Source: Eur Respir J 2012; 40: 1344-1353 Year: 2012 Performance of rapid, bedside whole blood C-reactive protein (CRP) test as a diagnostic test for bacterial infection and pneumonia in patients with acute exacerbation of chronic obstructive pulmonary disease (AE COPD) Source: Eur Respir J 2007; 30: Suppl. 51, 557s Year: 2007 Is CRP a reliable diagnostic tool for infective exacerbations of COPD? Source: Annual Congress 2013 –Difficult and rare respiratory infections Year: 2013 Procalcitonin versus C-reactive protein in the management of severe acute exacerbations of COPD Source: Annual Congress 2010 - Aetiology and outcomes of infective exacerbations of COPD Year: 2010 Usefulness of inflammatory markers: procalcitonin, neopterin, C-reactive protein and MR-proANP in the follow-up of patients with chronic obstructive pulmonary disease Source: Annual Congress 2008 - Biomarkers and antibiotic treatment of exacerbations of COPD Year: 2008 Procalcitonin use in acute exacerbations of COPD Source: Annual Congress 2011 - COPD exacerbation Year: 2011 Clinical value of C-reactive protein in severe acute exacerbations of COPD Source: Annual Congress 2005 - COPD - acute exacerbations Year: 2005 COPD, asthma and C-reactive protein Source: Eur Respir J 2006; 27: 874-876 Year: 2006 Evaluation of procalcitonin (PCT) and neopterin levels in acute exacerbations of COPD Source: Annual Congress 2005 - Acute and chronic infections in COPD Year: 2005 The prognostic value of cardiac and inflammatory biomarkers in acute exacerbations of COPD Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 Serum C-reactive protein 14 days after a COPD exacerbation and time to the next exacerbation Source: Eur Respir J 2006; 28: Suppl. 50, 177s Year: 2006 Are C-reactive protein levels associated with bacteria in COPD exacerbations? Source: Eur Respir J 2015; 45: 1515-1516 Year: 2015 Are C-reactive protein levels associated with bacteria in COPD exacerbations? Source: Eur Respir J 2015; 45: 1514-1515 Year: 2015 Combined serum eosinophil count and procalcitonin level as a marker of bacterial infection in acute exacerbation of chronic obstructive pulmonary disease Source: International Congress 2016 – Systemic biomarkers Year: 2016 Procalcitonin and C-reactive protein levels in infective attacks of COPD Source: Eur Respir J 2003; 22: Suppl. 45, 337s Year: 2003